Stocks
Seagen Inc.SGEN
NASDAQHealthcareBiotechnology$228.74-0.07%
A biotechnology company focused on developing and commercializing targeted cancer therapies, particularly antibody-drug conjugates that deliver chemotherapy directly to tumor cells. Its portfolio includes approved oncology treatments such as Adcetris, Padcev, Tukysa, and Tivdak, alongside a pipeline...
Market Cap: $43.2B52W Range: $126.47 – $228.96
Congressional Interest in Seagen Inc. (SGEN)
8 members of Congress have disclosed 17 trades in Seagen Inc. (SGEN), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 12 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
17
Unique Politicians
8
Buys
5
Sells
12
Who in Congress Is Trading SGEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-12-05 | Rohit Khanna | sell | $1K – $15K |
| 2023-10-27 | Josh Gottheimer | sell | $1K – $15K |